Noninvasive Assessment of Cerebral Perfusion and Oxygenation in Acute Ischemic Stroke by Near-Infrared SpectroscopyTerborg C.a, c · Gröschel K.a, d · Petrovitch A.b · Ringer T.a · Schnaudigel S.a, d · Witte O.W.a · Kastrup A.a, d
aDepartment of Neurology, and bInstitute of Diagnostic and Interventional Radiology, Friedrich Schiller University Jena, Jena, cDepartment of Neurology, Asklepios Klinik St. Georg, Hamburg, and dDepartment of Neurology, Georg August University of Göttingen, Göttingen, Germany
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: In acute stroke patients, there is a need for noninvasive measurement to monitor blood flow-based therapies. We investigated the utility of near-infrared spectroscopy (NIRS) to determine cerebral perfusion in these patients. Methods: Eleven patients were investigated within 1.4 ± 2.2 days after onset of an ischemic middle cerebral artery infarction by monitoring the kinetics of an intravenous bolus of indocyanine green (ICG). For ICG kinetics, bolus peak time, time to peak (TTP = time between 0 and 100% ICG maximum), maximum ICG concentration, rise time (time between 10 and 90% ICG maximum), slope (maximum ICG/TTP), and blood flow index (BFI = maximum ICG/rise time) were obtained. Perfusion-weighted MRI (PWI) and NIRS measurements were performed within 24 h, and the interhemispherical differences of TTP values were compared. Results: Stroke patients showed an increased bolus peak time (p < 0.02), TTP (p < 0.01), and rise time (p < 0.01), whereas slope (p < 0.01) and BFI (p < 0.01) were diminished at the site of infarction as compared to the unaffected hemisphere. The interhemispherical differences of TTP as measured by PWI and NIRS were closely correlated (r = 0.86). Conclusions: Noninvasive measurements of cerebral ICG kinetics by NIRS provide a useful means of detecting cerebral perfusion deficits in patients with acute stroke, which correlate well with those obtained by PWI.
© 2009 S. Karger AG, Basel
- Fisher M: Characterizing the target of acute stroke therapy. Stroke 1997;28:866–872.
- Rother J, Schellinger PD, Gass A, Siebler M, Villringer A, Fiebach JB, Fiehler J, Jansen O, Kucinski T, Schoder V, Szabo K, Junge-Hulsing GJ, Hennerici M, Zeumer H, Sartor K, Weiller C, Hacke W: Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. Stroke 2002;33:2438–2445.
- Neumann-Haefelin T, du Mesnil de Rochemont R, Fiebach JB, Gass A, Nolte C, Kucinski T, Rother J, Siebler M, Singer OC, Szabo K, Villringer A, Schellinger PD: Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke 2004;35:109–114.
- Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581–1587.
- Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317–1329.
- Rowat AM, Dennis MS, Wardlaw JM: Hypoxaemia in acute stroke is frequent and worsens outcome. Cerebrovasc Dis 2006;21:166–172.
- Yong M, Diener H-C, Kaste M, Mau J: Characteristics of blood pressure profiles as predictors of long-term outcome after acute ischemic stroke. Stroke 2005;36:2619–2625.
- Reith J, Jorgensen HS, Pedersen PM, Nakayama H, Raaschou HO, Jeppesen LL, Olsen TS: Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 1996;347:422–425.
- Hillis AE, Ulatowski JA, Barker PB, Torbey M, Ziai W, Beauchamp NJ, Oh S, Wityk RJ: A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke. Cerebrovasc Dis 2003;16:236–246.
- Rordorf G, Cramer SC, Efird JT, Schwamm LH, Buonanno F, Koroshetz WJ: Pharmacological elevation of blood pressure in acute stroke: clinical effects and safety. Stroke 1997;28:2133–2138.
- Mistri AK, Robinson TG, Potter JF: Pressor therapy in acute ischemic stroke: systematic review. Stroke 2006;37:1565–1571.
- Kuebler WM, Sckell A, Habler O, Kleen M, Kuhnle GE, Welte M, Messmer K, Goetz AE: Noninvasive measurement of regional cerebral blood flow by near-infrared spectroscopy and indocyanine green. J Cereb Blood Flow Metab 1998;18:445–456.
Terborg C, Bramer S, Harscher S, Simon M, Witte OW: Bedside assessment of cerebral perfusion reductions in patients with acute ischemic stroke by near-infrared spectroscopy and indocyanine green. J Neurol Neurosurg Psychiatry 2003;75:38–42.
- Suzuki S, Takasaki S, Ozaki T, Kobayashi Y: A tissue oxygenation monitor using NIR spatially resolved spectroscopy. Proc SPIE 1999;3597:582–592.
- Homan RW, Herman J, Purdy P: Cerebral location of international 10–20-system electrode placement. Electroencephalogr Clin Neurophysiol 1987;66:376–382.
- Sobesky J, Zaro Weber O, Lehnhardt FG, Hesselmann V, Thiel A, Dohmen C, Jacobs A, Neveling M, Heiss WD: Which time-to-peak threshold best identifies penumbral flow? A comparison of perfusion-weighted magnetic resonance imaging and positron emission tomography in acute ischemic stroke. Stroke 2004;35:2843–2847.
- Heiss WD, Sobesky J, Hesselmann V: Identifying thresholds for penumbra and irreversible tissue damage. Stroke 2004;35:2671–2674.
- Grandin CB, Duprez TP, Smith AM, Oppenheim C, Peeters A, Robert AR, Cosnard G: Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. Radiology 2002;223:361–370.
- Hermier M, Nighoghossian N, Adeleine P, Berthezene Y, Derex L, Yilmaz H, Dugor JF, Dardel P, Cotton F, Philippeau F, Trouillas P, Froment JC: Early magnetic resonance imaging prediction of arterial recanalization and late infarct volume in acute carotid artery stroke. J Cereb Blood Flow Metab 2003;23:240–248.
- Keller E, Wietasch G, Ringleb P, Scholz M, Schwarz S, Stingele R, Schwab S, Hanley D, Hacke W: Bedside monitoring of cerebral blood flow in patients with acute hemispheric stroke. Crit Care Med 2000;28:511–516.
- Tamura H, Hatazawa J, Toyoshima H, Shimosegawa E, Okudera T: Detection of deoxygenation-related signal change in acute ischemic stroke patients by T2*-weighted magnetic resonance imaging. Stroke 2002;33:967–971.
- Hermier M, Nighoghossian N, Derex L, Wiart M, Nemoz C, Berthezene Y, Froment JC: Hypointense leptomeningeal vessels at T2*-weighted MRI in acute ischemic stroke. Neurology 2005;65:652–653.
- Geisler BS, Brandhoff F, Fiehler J, Saager C, Speck O, Rother J, Zeumer H, Kucinski T: Blood-oxygen-level-dependent MRI allows metabolic description of tissue at risk in acute stroke patients. Stroke 2006;37:1778–1784.
- Harris DN, Cowans FM, Wertheim DA: NIRS in the temporal region – Strong influence of external carotid artery. Adv Exp Med Biol 1994;345:825–828.
- Smielewski P, Czosnyka M, Pickard JD, Kirkpatrick P: Clinical evaluation of near-infrared spectroscopy for testing cerebrovascular reactivity in patients with carotid artery disease. Stroke 1997;28:331–338.
- Rothoerl RD, Schebesch KM, Faltermeier R, Woertgen C, Brawanski A: Lack of correlation between Xenon133 and near infrared spectroscopy/indocyanine green rCBF measurements. Neurol Res 2003;25:528–532.
- Keller E, Nadler A, Alkhadi H, Kollias S, Yonekawa Y, Niederer P: Noninvasive measurement of regional cerebral blood flow and regional cerebral blood volume by near-infrared spectroscopy and indocynaine green dye dilution. Neuroimage 2003;20:828–839.
- Villringer K, Minoshima S, Hock C, Obrig H, Ziegler S, Dirnagl U, Schwaiger M, Villringer A: Assessment of local brain activation. A simultaneous pet and near-infrared spectroscopy study. Adv Exp Med Biol 1997;413:149–153.
- Gora F, Shinde S, Elwell CE, Goldstone JC, Cope M, Delpy DT, Smith M: Noninvasive measurement of cerebral blood flow in adults using near-infrared spectroscopy and indocyanine green: a pilot study. J Neurosurg Anesthesiol 2002;14:218–222.
- Wagner BP, Gertsch S, Amann RA, Pfenninger J: Reproducibility of the blood flow index as noninvasive, bedside estimation of cerebral blood flow. Intensive Care Med 2003;29:196–200.
- Leung TS, Tachtsidis I, Tisdall M, Smith M, Delpy DT, Elwell CE: Theoretical investigation of measuring cerebral blood flow in the adult human head using bolus indocyanine green injection and near-infrared spectroscopy. Appl Opt 2007;46:1604–1614.
- Liebert A, Wabnitz H, Steinbrink J, Obrig H, Moller M, Macdonald R, Villringer A, Rinneberg H: Time-resolved multidistance near-infrared spectroscopy of the adult head: intracerebral and extracerebral absorption changes from moments of distribution of times of flight of photons. Appl Opt 2004;43:3037–3047.
- Liebert A, Wabnitz H, Steinbrink J, Moller M, Macdonald R, Rinneberg H, Villringer A, Obrig H: Bed-side assessment of cerebral perfusion in stroke patients based on optical monitoring of a dye bolus by time-resolved diffuse reflectance. Neuroimage 2005;24:426–435.
- Keller E, Ishihara H, Nadler A, Niederer P, Seifert B, Yonekawa Y, Frei K: Evaluation of brain toxicity following near infrared light exposure after indocyanine green dye injection. J Neurosci Methods 2002;117:23–31.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.